ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fibroblasts"

  • Abstract Number: 771 • 2014 ACR/ARHP Annual Meeting

    Development of a Bifluorescent Lineage Tracker Reporter Mouse Strain to Analyze the Phenotypic Conversion of Endothelial Cells into Myofibroblasts in Vivo. Application to Study the Synergistic Effects of Endothelin-1 on TGF-β1-Induced Endothelial-to-Mesenchymal Transition

    Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Endothelial-to-mesenchymal transition (EndoMT) may be a crucial pathway in generating activated myofibroblasts, cells that play a pivotal role in the development of tissue and…
  • Abstract Number: 1962 • 2014 ACR/ARHP Annual Meeting

    Inflammatory Properties of Inhibitor of DNA Binding 1 As a Unique Fibroblast Derived Nuclear Protein

    Gautam Edhayan1, Christine M. Ha1, Ray A. Ohara1, Takeo Isozaki1, M. Asif Amin1, Ali Arbab2, Pei-Suen Tsou3, Phillip L. Campbell4, Elena Schiopu3, Dinesh Khanna3, Rachel Morgan1, Sean C. Friday1, David A. Fox1 and Jeffrey Ruth1, 1Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 2Georgia Regents University, Augusta, GA, 3University of Michigan Scleroderma Program, Ann Arbor, MI, 4Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

    Background/Purpose: Inhibitor of DNA binding 1 (Id1) is a nuclear protein containing a basic helix-loop-helix (bHLH) domain that regulates cell growth by selective binding and…
  • Abstract Number: 769 • 2014 ACR/ARHP Annual Meeting

    Anti-Fibrotic Effects of an Investigational Drug: Bis-Oxetanyl Sulfoxide

    Logan Mlakar1, Takahisa Takihara2, Melissa Sprachman3, Peter Wipf4 and Carol Feghali-Bostwick1, 1Medical University of South Carolina, Charleston, SC, 2Tokai University School of Medicine, Kanagawa, Japan, 3Massachusetts General Hospital, Boston, MA, 4Chemisry, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose:   The hallmark of pulmonary fibrosis is thickening and scarring of the tissue caused by increased deposition of extracellular matrix (ECM) proteins like collagen…
  • Abstract Number: 1796 • 2014 ACR/ARHP Annual Meeting

    Autotaxin Is Highly Expressed in Systemic Sclerosis (SSc) Skin, Mediates Dermal Fibrosis Via IL-6, and Is a Target for SSc Therapy

    Flavia V. Castelino1,2, Leaya M. George3, Gretchen Bain4, Lance Goulet5, Robert Lafyatis6 and Andrew M. Tager3,7, 1Rheumatology, Massachusetts General Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Pulmonary Unit, Massachusetts General Hospital, Boston, MA, 4Biology, PharmAkea Pharmaceuticals, San Diego, CA, 5PharmAkea Pharmaceuticals, San Diego, CA, 6Rheumatology, Boston University School of Medicine, Boston, MA, 7Massachusetts General Hospital, Boston, MA

    Background/Purpose Autotaxin (ATX) is an enzyme present in biological fluids that is responsible for the production of the lipid mediator, lysophosphatidic acid (LPA). We previously…
  • Abstract Number: 749 • 2014 ACR/ARHP Annual Meeting

    Progranulin Overproduction Due to Fli1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor a in Systemic Sclerosis

    Yohei Ichimura, Yoshihide Asano, Kaname Akamata, Shinji Noda, Takashi Taniguchi, Takehiro Takahashi, Tetsuo Toyama, Yayoi Tada, Makoto Sugaya, Shinichi Sato and Takafumi Kadono, Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan

    Background/Purpose: Systemic sclerosis (SSc) is a multisystem fibrotic connective tissue disease characterized by a dysregulated activation of fibroblasts following inflammation, autoimmune attacks, and vascular injuries.…
  • Abstract Number: 1739 • 2014 ACR/ARHP Annual Meeting

    Immunomodulatory Properties of CD271+ and CD271- Synovial Mesenchymal Cells

    Alicia Usategui1, Manuel J. Del Rey1, Regina Faré1, Gabriel Criado2, Vanessa Miranda1, Juan D. Cañete3 and Jose L. Pablos1, 1Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 2Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 3Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain

    Background/Purpose Mesenchymal stem cells (MSC) have been isolated from synovium and represent a fraction of synovial fibroblast (SF) cultures. CD271+ is considered a MSC surface…
  • Abstract Number: 327 • 2014 ACR/ARHP Annual Meeting

    AMPK Activation in Inflammatory Arthritis

    Monica Guma1, Yun Wang2 and Ru Liu-Bryan2, 1Division of Rheumatology, Allergy and Immunology, University of California, San Diego, La Jolla, CA, 2UCSD/VAMC, La Jolla, CA

    Background/Purpose: AMP-activated protein kinase (AMPK) is a serine/threonine protein kinase involved in the regulation of cellular energy homeostasis. It is a central regulator of both…
  • Abstract Number: 1728 • 2014 ACR/ARHP Annual Meeting

    Bromodomain Inhibitor JQ1 Modulates Collagen Processing and Ameliorates Bleomycin Induced Dermal Fibrosis in Mice

    Sarah Trinder1, Mary Tarriela2, Adrian Gilbane1, Robert Good3, Xu Shi-Wen4, David Abraham5 and Alan M. Holmes6, 1Rheumatology and Connective Tissue Diseases, UCL, London, United Kingdom, 2Centre for Rheumatology and Connective Tissue Diseases, London, United Kingdom, 3Rheumatology and Connective Tissue Diseases, UCL, LONDON, United Kingdom, 4Centre for Rheumatology and Connective Tissue Diseases, UCL, LONDON, United Kingdom, 5Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 6Centre for Rheumatology and Connective Tissue Diseases, UCL, London, United Kingdom

    Background/Purpose: Systemic sclerosis (SSc) is a complex pro-inflammatory scarring disease, characterised by elevated deposition of extracellular matrix (ECM) proteins, in particular collagen type I.  The…
  • Abstract Number: 324 • 2014 ACR/ARHP Annual Meeting

    Regulation of TNF-α-Mediated Activation of Rheumatoid Synovial Fibroblasts By Transcription Factor Snail

    Chrong-Reen Wang1,2, Shih-Yao Chen3, Ai-Li Shiau4, I-Ming Jou5,6, Ming-Fei Liu1,2 and Chao-Liang Wu3, 1Internal Medicine, National Cheng Kung University Medical College, Tainan, Taiwan, 2Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, 3Biochemistry and Molecular Biology, National Cheng Kung University Medical College, Tainan, Taiwan, 4Microbiology and Immunology, National Cheng Kung University Medical College, Tainan, Taiwan, 5Orthopedics, National Cheng Kung University Medical College, Tainan, Taiwan, 6Orthopedics, National Cheng Kung University Hospital, Tainan, Taiwan

    Background/Purpose: Transcription factor Snail plays active roles in various biological functions and is involved in many disease states. We hypothesized that this molecule regulates TNF-α-mediated…
  • Abstract Number: 1710 • 2014 ACR/ARHP Annual Meeting

    Endothelin-1 Is a Downstream Mediator of Profibrotic Effects by Transforming Growth Factor-β1 in Systemic Sclerosis Skin Fibroblasts

    Tomoaki Higuchi1, Yasushi Kawaguchi1, Akiko Tochimoto1, Yuko Ota2, Yasuhiro Katsumata1, Takahisa Gono1, Masanori Hanaoka1, Yuko Okamoto1, Hidenaga Kawasumi1 and Hisashi Yamanaka3, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 210-22 Kawada-Cha Shinjuku-Ku, Tokyo Women's Medical University, Tokyo, Japan, 3Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose Systemic sclerosis (SSc) is an autoimmune connective tissue disorder characterized by excess collagen deposition, vascular changes and production of autoantibodies that affects multiple organs.…
  • Abstract Number: 1704 • 2014 ACR/ARHP Annual Meeting

    CXCL4 Promotes Fibrosis By Increasing Expression of Extracellular Matrix Modifying Factors and By Facilitating Epithelial/Endothelial Mesenchymal Transition

    W. Marut1, A.J. Affandi1, A. Limpers1 and T.R.D.J. Radstake2, 1Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose Systemic sclerosis (SSc) is a degenerative disorder, characterized by vascular abnormalities and immunological disturbances followed by excessive fibrosis in multiple organ systems. In a…
  • Abstract Number: 2564 • 2013 ACR/ARHP Annual Meeting

    Functional Activation Of The TRPV1 and TRPV2 Non-Selective Cation Channels Potentiates TGF-β1-Induced Endothelial-To-Mesenchymal Transition In Murine Pulmonary Endothelial Cells Suggest a Potential Role Of Trpv Channels In The Pathogenesis Of Systemic Sclerosis

    Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Transient receptor potential (Trp) cation channel, subfamily V (TRPV) members can impact a diverse range of vascular functions, including vascular tone, vascular permeability, mechanosensing,…
  • Abstract Number: 652 • 2013 ACR/ARHP Annual Meeting

    Pirfenidone and BIBF1120 Suppress Collagen Synthesis In Skin Fibroblast From Patients With Systemic Sclerosis

    Yuko Ota1, Yasushi Kawaguchi1, Kae Takagi1, Hisae Ichida1, Yasuhiro Katsumata1, Takahisa Gono1, Yuko Okamoto1, Tomoaki Higuchi2, Hidenaga Kawasumi1 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute Of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: Pirfenidone (5-methyle-1-phenyl-2- [1H]-pyridone) and BIBF1120 (Nintedanib) are currently evaluated in clinical trials as a potential idiopathic pulmonary fibrosis (IPF). Pirfenidone was approved as the…
  • Abstract Number: 2565 • 2013 ACR/ARHP Annual Meeting

    Synergistic Effects Of Endothelin-1 On Transforming Growth Factor-β1 (TGF-β1) Induced Endothelial-To-Mesenchymal Transition. A Novel Mechanism For The Fibrogenic Effects Of Endothelin

    Peter J. Wermuth, Zhaodong Li and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: The process of endothelial-to-mesenchymal transition (EndoMT) may be a crucial pathway in the generation of activated myofibroblasts, cells that play a pivotal role in…
  • Abstract Number: 2560 • 2013 ACR/ARHP Annual Meeting

    Analysis Of Global Gene Expression Of Pulmonary Endothelial Cells From Caveolin-1 Knock-Out Mice

    Sonsoles Piera-Velazquez1, Zhaodong Li1, Sankar Addya2, Peter J. Wermuth1 and Sergio A. Jimenez1, 1Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA, 2Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

    Background/Purpose: Caveolin-1 (Cav-1) deficiency has recently been shown to participate in the pathogenesis of tissue fibrosis in Systemic Sclerosis (SSc). Although the mechanisms involved have…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology